Eosinophilic esophagitis EoE treatment trial (BUL-8)
Summary
A clinical research study to evaluating the safety and tolerability of 2 mg once daily vs. 1 mg twice daily budesonide orodispersible tablets in study participants with eosinophilic
esophagitis
Eligibility
Eligible ages: 18 to 75
Inclusion criteria:
You may be eligible to participate in this trial if you are:
- between the age of 18 to 75 years
- have been diagnosed with eosinophilic esophagitis
Doctors will also evaluate other criteria to make sure you qualify for the study.
Exclusion criteria:
You may not be eligible to participate in this trial if you:
- have gastroesophageal reflux disease (GERD), Achalasia, sclerosis
- female who is breast feeding or pregnant
Doctors will also evaluate other criteria to make sure you qualify for the study.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
You may contact our Research Coordinator, Eva Mak, with any questions or concerns about the research or your participation in this study. eva.mak@ucalgary.ca 403-210-7604
Principal investigator:
Milli Gupta
Clinical trial:
Yes
REB-ID:
REB22-0539